,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1469,1,1,,29216369,430461,Active,189491771.0,7068.0,25.1189,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
1,1471,2,1,,29216369,430461,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
2,1479,1,2,,29216369,430461,Active,189491771.0,7068.0,44.6684,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
3,1490,2,1,,29216369,430461,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
4,1688,1,1,,29216369,430461,Active,90903231.0,3064.0,1.0,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
5,1766,1,1,,29216369,430461,Inconclusive,18860839.0,4221.0,1.2589,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
6,1766,1,1,,29216369,430461,Inconclusive,56550039.0,4297.0,1.2589,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
7,1768,1,1,,29216369,430461,Inconclusive,18860839.0,4221.0,25.1189,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
8,1768,1,1,,29216369,430461,Inconclusive,56550039.0,4297.0,25.1189,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
9,2528,1,2,,29216369,430461,Inconclusive,4557365.0,641.0,31.6228,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
10,2546,1,1,,29216369,430461,Inconclusive,188536040.0,19885.0,11.2202,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
11,2551,1,1,,29216369,430461,Active,188536040.0,19885.0,11.2202,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
12,2662,2,1,,29216369,430461,Inconclusive,56550039.0,4297.0,39.8107,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
13,485290,1,1,,29216369,430461,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
14,492961,1,1,,29216369,430461,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
15,504327,1,1,,29216369,430461,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
16,504332,1,1,,29216369,430461,Inconclusive,168985070.0,,3.1623,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
17,504749,1,3,,29216369,430461,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
18,504749,1,3,1.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
19,504749,1,3,2.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
20,504749,1,3,3.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
21,504749,1,3,4.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
22,504749,1,3,5.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
23,504749,1,3,6.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
24,504749,1,3,7.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
25,504749,1,3,8.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
26,504749,1,3,9.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
27,504749,1,3,10.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
28,504749,1,3,11.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
29,504749,1,3,12.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
30,504749,1,3,13.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
31,504749,1,3,14.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
32,504749,1,3,15.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
33,504749,1,3,16.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
34,504749,1,3,17.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
35,504749,1,3,18.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
36,504749,1,3,19.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
37,504749,1,3,20.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
38,504749,1,3,21.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
39,504749,1,3,22.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
40,504749,1,3,23.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
41,504749,1,3,24.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
42,504749,1,3,25.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
43,504749,1,3,26.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
44,504749,1,3,27.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
45,504749,1,3,28.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
46,504749,1,3,29.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
47,504749,1,3,30.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
48,504749,1,3,31.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
49,504749,1,3,32.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
50,504749,1,3,33.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
51,504749,1,3,34.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
52,504749,1,3,35.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
53,504749,1,3,36.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
54,504749,1,3,37.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
55,504749,1,3,38.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
56,504749,1,3,39.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
57,504749,1,3,40.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
58,504749,1,3,41.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
59,504749,1,3,42.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
60,504749,1,3,43.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
61,504749,1,3,44.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
62,504749,1,3,45.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
63,504749,1,3,46.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
64,504749,1,3,47.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
65,504749,1,3,48.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
66,504749,1,3,49.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
67,504749,1,3,50.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
68,504749,1,3,51.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
69,504749,1,3,52.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
70,504749,1,3,53.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
71,504749,1,3,54.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
72,504749,1,3,55.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
73,504749,1,3,56.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
74,504749,1,3,57.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
75,504749,1,3,58.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
76,504749,1,3,59.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
77,504749,1,3,60.0,29216369,430461,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
78,504749,1,3,61.0,29216369,430461,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
79,504832,1,1,,29216369,430461,Active,,,1.5101,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
80,504834,1,1,,29216369,430461,Active,,,0.8492,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
81,504847,1,1,,29216369,430461,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
82,504865,1,1,,29216369,430461,Active,118600387.0,7398.0,22.3872,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
83,588453,1,1,,124892325,430461,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
84,588456,1,1,,124892325,430461,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
85,588579,1,1,,29216369,430461,Active,7705344.0,51426.0,7.0795,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
86,588579,1,1,,124892325,430461,Active,7705344.0,51426.0,25.1189,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
87,588590,1,1,,124892325,430461,Inconclusive,154350220.0,11201.0,50.1187,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
88,588795,1,1,,124892325,430461,Inconclusive,4758356.0,2237.0,56.2341,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
89,588855,1,1,,124892325,430461,Active,18418623.0,4088.0,1.5849,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
90,588856,1,1,,124892325,430461,Inactive,,,35.4813,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
91,602310,1,2,,124892325,430461,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
92,602332,1,1,,29216369,430461,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
93,602332,1,1,,124892325,430461,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
94,624030,1,2,,29216369,430461,Inconclusive,160794.0,,11.4239,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
95,624031,1,2,,29216369,430461,Inconclusive,,,2.2794,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
96,624032,1,2,,29216369,430461,Inconclusive,8393992.0,24660.0,40.5334,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
97,624044,1,2,,29216369,430461,Active,8393992.0,24660.0,0.0999,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
98,624160,1,1,,29216369,430461,Active,,,4.4843,Potency,qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Fluorescein FP,Confirmatory,,
99,624161,1,1,,29216369,430461,Active,,,20.0308,Potency,qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Texas Red FP,Confirmatory,,
100,624162,1,2,,29216369,430461,Inactive,,,86.2752,Potency,qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: HTRF Assay,Confirmatory,,
101,624170,1,1,,29216369,430461,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
102,624172,1,1,,29216369,430461,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
103,624173,1,3,,29216369,430461,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
104,624178,1,1,,124892325,430461,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
105,624202,1,1,,124892325,430461,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
106,624263,1,1,,124892325,430461,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
107,624263,1,1,,124892325,430461,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
108,624296,1,1,,29216369,430461,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
109,624297,1,1,,29216369,430461,Inconclusive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
110,624414,1,1,,124892325,430461,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
111,651965,1,1,,124892325,430461,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
112,652106,1,1,,124892325,430461,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
113,686978,1,1,,124892325,430461,Active,79154014.0,55775.0,0.0251,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
114,686979,1,1,,124892325,430461,Active,79154014.0,55775.0,0.1,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
115,720522,1,1,,124892325,430461,Inactive,122893032.0,,,Potency,Nrf2 qHTS screen for inhibitors: Purified Fluc Biochemical Counterscreen for Hit Validation,Confirmatory,,
116,720523,1,1,,124892325,430461,Inconclusive,,,2.9093,Potency,Nrf2 qHTS screen for inhibitors: A549 ARE-Fluc Cytotoxicity Counterscreen for Hit Validation,Confirmatory,,
117,720524,1,1,,124892325,430461,Active,224028257.0,4780.0,0.4611,Potency,Nrf2 qHTS screen for inhibitors: Nrf2 A549 ARE-Fluc Confirmation Assay for Hit Validation,Confirmatory,,
118,720579,2,1,,124892325,430461,Inactive,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
119,720580,1,1,,124892325,430461,Inactive,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
120,1259416,1,2,,375178446,430461,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
121,1259421,1,1,,375178446,430461,Active,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
